192 related articles for article (PubMed ID: 33771179)
1. MR-guided stereotactic body radiation therapy for primary cardiac sarcomas.
Corradini S; von Bestenbostel R; Romano A; Curta A; Di Gioia D; Placidi L; Niyazi M; Boldrini L
Radiat Oncol; 2021 Mar; 16(1):60. PubMed ID: 33771179
[TBL] [Abstract][Full Text] [Related]
2. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
3. MR-Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis - a case report.
Batumalai V; Carr M; Jameson M; Crawford D; Jelen U; Pagulayan C; Twentyman T; Hong A; de Leon J
J Med Radiat Sci; 2023 Jun; 70(2):199-205. PubMed ID: 36890690
[TBL] [Abstract][Full Text] [Related]
4. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
5. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
7. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
8. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
[TBL] [Abstract][Full Text] [Related]
9. Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.
Daamen LA; de Mol van Otterloo SR; van Goor IWJM; Eijkelenkamp H; Erickson BA; Hall WA; Heerkens HD; Meijer GJ; Molenaar IQ; van Santvoort HC; Verkooijen HM; Intven MPW
Acta Oncol; 2022 Jan; 61(1):111-115. PubMed ID: 34879792
[TBL] [Abstract][Full Text] [Related]
10. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach.
Boldrini L; Romano A; Mariani S; Cusumano D; Catucci F; Placidi L; Mattiucci GC; Chiloiro G; Cellini F; Gambacorta MA; Indovina L; Valentini V
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2057-2068. PubMed ID: 33398447
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
Regnery S; Ristau J; Weykamp F; Hoegen P; Sprengel SD; Paul KM; Buchele C; Klüter S; Rippke C; Renkamp CK; Pohl M; Meis J; Welzel T; Adeberg S; Koerber SA; Debus J; Hörner-Rieber J
Radiat Oncol; 2022 May; 17(1):102. PubMed ID: 35614486
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial.
Regnery S; de Colle C; Eze C; Corradini S; Thieke C; Sedlaczek O; Schlemmer HP; Dinkel J; Seith F; Kopp-Schneider A; Gillmann C; Renkamp CK; Landry G; Thorwarth D; Zips D; Belka C; Jäkel O; Debus J; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):74. PubMed ID: 37143154
[TBL] [Abstract][Full Text] [Related]
14. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
[TBL] [Abstract][Full Text] [Related]
15. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
[TBL] [Abstract][Full Text] [Related]
16. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
17. MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis.
van Sörnsen de Koste JR; Palacios MA; Bruynzeel AME; Slotman BJ; Senan S; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):858-866. PubMed ID: 30061007
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
Finazzi T; Haasbeek CJA; Spoelstra FOB; Palacios MA; Admiraal MA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):270-278. PubMed ID: 32105742
[TBL] [Abstract][Full Text] [Related]
19. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
20. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
